BioLife Solutions (BLFS) Tops Q4 EPS by 4c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.25 -0.79%
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $32.7 million versus the consensus estimate of $33.4 million.
GUIDANCE:
BioLife Solutions sees FY2024 revenue of $95.5-100 million, versus the consensus of $106.3 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
